Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 2,344 shares at $974.86 ($2.3M) on 2024-05-28, disclosed to the SEC on 2024-05-29.
Scheduled sale ($2.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $974.86 | 1,172 | $1.1M | 50.0% |
| 2 | $974.86 | 1,172 | $1.1M | 50.0% |
| Total | $974.86 avg | 2,344 | $2.3M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |